Coloplast A/S (OTCMKTS:CLPBY) Share Price Passes Above 50-Day Moving Average – Here’s Why

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY)’s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $6.09 and traded as high as $6.70. Coloplast A/S shares last traded at $6.68, with a volume of 106,689 shares.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Kepler Capital Markets raised shares of Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. The Goldman Sachs Group cut shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 7th. One research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Coloplast A/S presently has an average rating of “Hold”.

Coloplast A/S Trading Up 0.5%

The stock has a market capitalization of $15.05 billion, a P/E ratio of 47.71, a P/E/G ratio of 2.11 and a beta of 0.22. The company has a current ratio of 1.75, a quick ratio of 1.09 and a debt-to-equity ratio of 1.66. The business has a 50-day moving average price of $6.09 and a two-hundred day moving average price of $6.86.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings results on Tuesday, May 12th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The company had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.11 billion. Coloplast A/S had a return on equity of 33.15% and a net margin of 7.46%. On average, analysts expect that Coloplast A/S Sponsored ADR will post 0.38 EPS for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.